These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 1382289)

  • 1. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
    Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies.
    Richter W; Eiermann TH; Endl J; Seissler J; Wolfahrt S; Brandt M; Jungfer H; Scherbaum WA
    Diabetologia; 1993 Aug; 36(8):785-90. PubMed ID: 7691667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
    Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
    J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
    Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
    Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies.
    Marshall MO; Høyer PE; Petersen JS; Hejnaes KR; Genovese S; Dyrberg T; Bottazzo GF
    J Autoimmun; 1994 Aug; 7(4):497-508. PubMed ID: 7980851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.
    Richter W; Shi Y; Baekkeskov S
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2832-6. PubMed ID: 7681990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
    DeAizpurua HJ; Honeyman MC; Harrison LC
    J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal autoantibodies from insulin-dependent diabetic patients: autoantibodies against beta-cell surface or cytoplasmic antigens.
    Houssaint E; Pogu S; Ouary M; Sai P
    Clin Exp Immunol; 1990 Oct; 82(1):44-51. PubMed ID: 1698582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
    J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
    Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
    Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I.
    Velloso LA; Winqvist O; Gustafsson J; Kämpe O; Karlsson FA
    Diabetologia; 1994 Jan; 37(1):61-9. PubMed ID: 8150232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase.
    Takino H; Kawasaki E; Yano M; Matsumoto K; Uotani S; Okuno S; Takao Y; Yamasaki H; Yamaguchi Y; Akazawa S
    J Autoimmun; 1994 Jun; 7(3):389-98. PubMed ID: 7916910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated.
    Madec AM; Rousset F; Ho S; Robert F; Thivolet C; Orgiazzi J; Lebecque S
    J Immunol; 1996 May; 156(9):3541-9. PubMed ID: 8617984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID).
    Petersen JS; Marshall MO; Baekkeskov S; Hejnaes KR; Høier-Madsen M; Dyrberg T
    Diabetologia; 1993 Jun; 36(6):510-5. PubMed ID: 8335172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase.
    Christie MR; Hollands JA; Brown TJ; Michelsen BK; Delovitch TL
    J Clin Invest; 1993 Jul; 92(1):240-8. PubMed ID: 8325989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of antibodies in sera from Type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme.
    Christie MR; Brown TJ; Cassidy D
    Diabetologia; 1992 Apr; 35(4):380-4. PubMed ID: 1516767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.
    Verge CF; Howard NJ; Rowley MJ; Mackay IR; Zimmet PZ; Egan M; Hulinska H; Hulinsky I; Silvestrini RA; Kamath S
    Diabetologia; 1994 Nov; 37(11):1113-20. PubMed ID: 7867883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.